Kidney Medicine (Mar 2019)

Anticoagulant-Related Nephropathy in Kidney Biopsy: A Single-Center Report of 41 Cases

  • Sergey V. Brodsky,
  • Anjali Satoskar,
  • Jessica Hemminger,
  • Brad Rovin,
  • Lee Hebert,
  • Margaret S. Ryan,
  • Tibor Nadasdy

Journal volume & issue
Vol. 1, no. 2
pp. 51 – 56

Abstract

Read online

Rationale & Objective: In 2009, the first case of acute kidney injury and occlusive red blood cell (RBC) tubular casts associated with a high international normalized ratio in a patient receiving warfarin was identified. This entity, named warfarin-related nephropathy, was later renamed anticoagulant-related nephropathy (ARN) after similar cases with other anticoagulants were described. We provide our 10-year experience with ARN based on a single-center kidney biopsy laboratory. Study Design: The kidney pathology database at the Ohio State University Wexner Medical Center (OSUWMC) was searched for native kidney biopsy cases consistent with ARN. Clinical data were obtained from patient medical records. Setting & Participants: Native kidney biopsies evaluated between January 1, 2009, and December 31, 2017 at OSUWMC. Results: Among 8,636 native kidney biopsies reviewed at the OSUWMC, there were 41 (0.5%) patients for whom deterioration in kidney function could not be explained by kidney biopsy findings alone if anticoagulation was not considered. There were 63% men and 95% were white; average age was 62 ± 14 years. Most were on warfarin therapy (N = 28), although cases were also attributed to direct-acting anticoagulants (N = 2), antiplatelet medications (N = 1), heparin or enoxaparin (N = 4), and disseminated intravascular coagulopathy (N = 6). Morphologically, there was acute tubular necrosis and RBC casts. The majority of biopsies had an underlying glomerular disease and many patients had positive serologic test results. In all these cases, the severity of kidney failure, RBC tubular casts, and hematuria were disproportionate to glomerular morphologic changes. Limitations: Selection bias in the decision to perform a kidney biopsy. Conclusions: ARN is an uncommon diagnosis in kidney pathology practice, but it should be considered when the number of RBC tubular casts is disproportionate to the severity of glomerular changes in a kidney biopsy in patients either receiving anticoagulation therapy or who presented with acute coagulopathy. Our data suggest that anticoagulation aggravates underlying glomerular diseases rather than directly affecting the glomerular filtration barrier. Index Words: Kidney biopsy, warfarin-related nephropathy, anticoagulants, acute kidney injury, hematuria